Primo Nutraceuticals Inc.
BUGVFOTCHealthcare
$0.00
$-0.00(-24.29%)
Market Cap$26
P/E Ratio—
52W High$0.000001
52W Low$0.000001
Primo Nutraceuticals Inc.（BUGVF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BUGVF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2019-07 |
|---|---|
| Revenue | |
| Revenue | $0.00B |
| Cost of Revenue | $0.00B |
| Gross Profit | $0.00B |
| Gross Margin %(computed) | — |
| Operating Expenses | |
| R&D Expenses | $0.00B |
| G&A Expenses | $0.00B |
| Total Operating Expenses | $0.00B |
| Operating Income | ($0.00B) |
| Operating Margin %(computed) | — |
| Interest Income | $0.00B |
| Interest Expense | $0.00B |
| Income Before Tax | ($0.00B) |
| Income Tax Expense | ($0.00B) |
| Net Income | ($0.00B) |
| Net Margin %(computed) | — |
| Per Share & EBITDA | |
| EPS (Basic) | $-0.88 |
| Wtd Avg Shares | 0.00B |
| EBITDA | ($0.00B) |
| EBITDA Margin %(computed) | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CAD · B
深入了解Primo Nutraceuticals Inc.
关于Primo Nutraceuticals Inc.（BUGVF）损益表
Primo Nutraceuticals Inc.（BUGVF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2019财年，BUGVF实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.00B)（净利率—）。
常见问题
BUGVF · 4 问Primo Nutraceuticals Inc.（BUGVF）2019财年营收为$0.00B，同比down—%。
BUGVF revenueBUGVF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09